ATH
Click for more information
0.00% 0.4¢ alterity therapeutics limited

Ann: Appendix 4E & Annual Report 2019, page-5

  1. sgsundy
    516 Posts.
    lightbulb Created with Sketch. 13
    clock Created with Sketch.
    30/08/19
    23:08
    Post #: 40255515
    ATH doesn't own the patents for antibiotics PBT2, but they should be the owner of the best synthetic routes and GMP facilities. They also have all the safety profiles and relevant clinical data of PBT2. ATH still has a chance to be a partner and share the profits from commercializing PBT2 as an antibiotics. Hope this comes to true... dream it possible
    ATH Price at posting: 2.6¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
MTL Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
ABY Adore Beauty appoints former David Jones exec as new CEO
right-arrow Created with Sketch.
DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $203.0K 45.14M

Buyers (Bids)

No. Vol. Price($)
104 103311567 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31829254 17
View Market Depth
Last trade - 10.53am 30/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.